Clinical Trial Update: An 18 Week Efficacy and Safety Study of Saxagliptin and Metformin XR Combination in Subjects With Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating the efficacy and safety of the saxagliptin and metformin XR combination in adults with Type 2 diabetes mellitus; results were posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Saxagliptin (saxagliptin)
• metformin XR (metformin)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2011-09-27